Efficacy and Tolerability of Nebivolol in Stage I–II Hypertension: A Pooled Analysis of Data From Three Randomized, Placebo-Controlled Monotherapy Trials-Reference-Cited by-同舟云学术

Efficacy and Tolerability of Nebivolol in Stage I–II Hypertension: A Pooled Analysis of Data From Three Randomized, Placebo-Controlled Monotherapy Trials

Published:2011-09 Issue:9 Volume:33 Page:1150-1161
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Weiss Robert J.,Saunders Elijah,Greathouse Mark

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. Beta-Adrenergic blockers: a 50-year historical perspective;Frishman;Am J Ther,2008

2. NICE removes beta blockers as first line treatment for hypertension;Mayor;BMJ,2006

3. Beta-blockers for hypertension;Wiysonge;Cochrane Database Syst Rev,2007

4. First-line drugs for hypertension;Wright;Cochrane Database Syst Rev,2009

5. Should beta blockers remain first choice in the treatment of primary hypertension?;Lindholm;Lancet,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nebivolol/valsartan combination for the treatment of hypertension: a review;Future Cardiology;2021-07

2. Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study;Journal of Hypertension;2020-03

3. Additivity of nebivolol/valsartan single-pill combinations versus other single-pill combinations for hypertension;The Journal of Clinical Hypertension;2017-11-05

4. Rationale for nebivolol/valsartan combination for hypertension;Journal of Hypertension;2017-09

5. Nebivolol attenuates cerebral vasospasm both by increasing endothelial nitric oxide and by decreasing oxidative stress in an experimental subarachnoid haemorrhage;British Journal of Neurosurgery;2017-03-23